Article by Julia Aube, Policy Trainee for Healthcare Delivery The COVID-19 pandemic has jeopardised the access and availability of medicines in the EU, therefore, making the EU more resilient regarding the supply of pharmaceuticals is a key objective of...
Our June newsletter is dedicated to the window of opportunity offered by the ongoing revision of the EU’s pharmaceutical legislation to improve access to effective and affordable medicines for everyone. Contrary to what the pharmaceutical industry claims, high prices...
European Alliance for Responsible R&D and Affordable Medicines The Alliance strives for the creation of an R&D system that is driven by public health needs and delivers medicines that are universally accessible and affordable. The Alliance is a free-to-join...
The European Public Health Alliance (EPHA), the European Public Health Association (EUPHA), the Association of Schools of Public Health in the European Region (ASPHER), and the World Federation of Public Health Associations (WFPHA), the leading European and...
WHO has been seeking public input to support the work of the Intergovernmental Negotiating Body (INB) in drafting and negotiating an international instrument to strengthen pandemic prevention, preparedness and response. In their first round of public hearings on 12-13...